Pregravidary preparation and management of first trimester pregnancy in women with reduced fertility
Abstract
Fertility disorders - infertility and miscarriage - are one of the most urgent problems in «obstetrics and gynecology)) specialty. The participation of sex hormones in the physiological processes of ovulation, implantation and subsequent gestation justifies the possibility of using their analogues in the practice of treating women with impaired fertility. Progesterone preparations are widely used for correction of menstrual cycle disorders, in programs of assisted reproductive technologies, for the prevention and treatment of gestational complications. The review presents the experience of russian and foreign researchers on the use of micronized progesterone preparations in the vaginal dosage form with the aim of restoring fertility and maintaining pregnancy in women with infertility and miscarriage.
About the Author
I. V. Kuznetsova
First Moscow State Medical University n.a. I. M. Sechenov
Russian Federation
Russian Federation
References
1. Zhang S, Lin H, Kong S, et al. Physiological and molecular determinants of embryo implantation. Mol Aspects Med. 2013; 34 (5): 939-980.
2. Aghajanova L, Shen S, Rojas AM, Fisher SJ, Irwin JC, Giudice LC. Comparative transcriptome analysis of human trophectoderm and embryonic stem cell-derived trophoblasts reveal key participants in early implantation. Biol Reprod. 2012; 86 (1): 1-21.
3. Achache H, Tsafrir A, Prus D, Reich R, Revel A. Defective endometrial prostaglandin synthesis identified in patients with repeated implantation failure undergoing in vitro fertilization. Fertil Steril. 2010; 94 (4): 1271-1278.
4. Altmae S, Martinez-Conejero JA, Salumets A, Simon C, Horcajadas JA, Stavreus-Evers A. Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Mol Hum Reprod. 2010; 16 (3): 178-187.
5. Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol. 2012; 357 (1-2): 108-118.
6. Salazar L, Calzada LL. The role of progesterone in endometrial estradiol- and progesterone-receptorsynthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol. 2007; 23 (4): 222-225.
7. Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol. 2007; 58 (3): 268-279.
8. Matsuzaki S, Darcha C, Maleysson E, Canis M, Mage G. Impaired down-regulation of E-cadherin and beta-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis. J Clin Endocrinol Metab. 2010; 95 (7): 3437-3445.
9. Domingues TS, Aquino AP, Barros B, et al. Egg donation of vitrified oocytes bank produces similar pregnancy rates by blastocyst transfer when compared to fresh cycle. J Assist Reprod Genet. 2017; 34 (11): 1553-1557.
10. Panay N, Pritsch M, Alt J. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study. Gynecol Endocrinol. 2007; 23 (11): 611-618.
11. Palomba S, Santagni S, La Sala GB. Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? J Ovarian Res. 2015; 8: 77.
12. Ткаченко Л. В., Линченко Н. А. Коррекция гормонального гомеостаза у женщин с бесплодием и недостаточностью лютеиновой фазы менструального цикла. Гинекология. 2014; 4: 24-27.
13. Сухих Г. Т., Осипьянц А. И., Мальцева Л. И., и др. Аномальное гиперметилирование генов Н0ХА10 и НОХА11 при бесплодии, ассоциированном с хроническим эндометритом. Акушерство и гинекология. 2015; 12: 69-74.
14. Khan MA, Hussain A, Sundaram MK, et al. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol Rep. 2015; 33 (4): 1976-1984.
15. Czyzyk A, Podfigurna A, Genazzani AR, Meczekalski B. The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility. Gynecol Endocrinol. 2017; 33 (6): 421-424.
16. Радзинский В. Е. Угроза спонтанного аборта: старые контраверсии-новые возможности. StatusPraesens 2014; 6 (17): 25-31.
17. Мальцева Л. И., Никогосян Д. М. Эффективность микронизированного прогестерона для профилактики невынашивания беременности. Гинекология 2015; 17 (2): 56-59.
18. Toth B, Jeschke U, Rogenhofer N. et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010; 85: 25-32.
19. Stephenson MD, McQuenn D, Winter M, Kliman HJ. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss. Fertil Steril. 2017; 107 (3): 684-690.
20. Ismail AM, Abbas AM, Ali MK, Amin AF. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med. 2018 Feb; 31 (3): 388-394. Epub 2017 Feb 15.
21. Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal Progesterone for Preventing Preterm Birth and Adverse Perinatal Outcomes in Singleton Gestations with a Short Cervix: A Meta-Analysis of Individual Patient Data. Am J Obstet Gynecol. 2017 Nov 16. pii: S 0002-9378(17)32343-8. Epub ahead of print.
22. Гончарова С. В., Башмакова Н. В. Потеря беременности: патогенетическая терапия и ее исходы у женщин группы высокого риска. Вопросы гинекологии, акушерства и перинатологии. 2014; 13 (3): 19-26.
23. Винокурова Е. А., Башмакова Н. В. Профилактика преждевременных родов у женщин с преждевременными родами в анамнезе и короткой шейкой матки. Акушерство и гинекология. 2016; 3: 19-27.
Review
For citations:
Kuznetsova I.V. Pregravidary preparation and management of first trimester pregnancy in women with reduced fertility. Medical alphabet. 2017;4(37):14-19. (In Russ.)
Views:
359
Email this article 